OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Development of therapeutic vaccines for the treatment of diseases
Yaomei Tian, Die Hu, Yuhua Li, et al.
Molecular Biomedicine (2022) Vol. 3, Iss. 1
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Can Vaccines Stop Cancer Before It Starts? Assessing the Promise of Prophylactic Immunization Against High-Risk Preneoplastic Lesions
Tamer A. Addissouky, Ibrahim El Tantawy El Sayed, Majeed M. A. Ali, et al.
Journal of Cellular Immunology (2023) Vol. 5, Iss. 4, pp. 127-140
Open Access | Times Cited: 18

TP53/mTORC1-mediated bidirectional regulation of PD-L1 modulates immune evasion in hepatocellular carcinoma
Jiong-Jie Yu, Sunbin Ling, Jiachen Hong, et al.
Journal for ImmunoTherapy of Cancer (2023) Vol. 11, Iss. 11, pp. e007479-e007479
Open Access | Times Cited: 17

The use of proteins and peptides-based therapy in managing and preventing pathogenic viruses
Esmail M. El‐Fakharany, Hamada El‐Gendi, Ahmed K. Saleh, et al.
International Journal of Biological Macromolecules (2024) Vol. 270, pp. 132254-132254
Closed Access | Times Cited: 5

Progress and prospects of mRNA-based drugs in pre-clinical and clinical applications
Yingying Shi, Miaoyuan Shi, Yì Wáng, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5

The role of artificial intelligence in pandemic responses: from epidemiological modeling to vaccine development
Mayur Suresh Gawande, N. N. Zade, Praveen Kumar, et al.
Molecular Biomedicine (2025) Vol. 6, Iss. 1
Open Access

Immunotherapy in Ophthalmic Oncology: Current Trends and Future Directions
Mouayad Masalkhi, Noura Wahoud, Bridget Moran, et al.
Journal of Clinical & Translational Ophthalmology (2025) Vol. 3, Iss. 1, pp. 1-1
Open Access

Harnessing phytochemicals: innovative strategies to enhance cancer immunotherapy
Qianru Zhu, Ruonan Zhang, Min Jin Ha, et al.
Drug Resistance Updates (2025) Vol. 79, pp. 101206-101206
Open Access

WISIT vaccines based on IL-31-derived peptides as a novel therapeutic approach for chronic pruritic dermatoses
Sabine Schmidhuber, James Dickie, Mihály Cserepes, et al.
PLoS ONE (2025) Vol. 20, Iss. 2, pp. e0318293-e0318293
Open Access

mRNA vaccine platforms: linking infectious disease prevention and cancer immunotherapy
Dariush Haghmorad, Majid Eslami, Niloufar Orooji, et al.
Frontiers in Bioengineering and Biotechnology (2025) Vol. 13
Open Access

Current Trends in Mucosal Melanomas: An Overview
Davide Adriano Santeufemia, Giuseppe Palmieri, Gianmaria Miolo, et al.
Cancers (2023) Vol. 15, Iss. 5, pp. 1356-1356
Open Access | Times Cited: 13

Biomanufacturing of glycosylated antibodies: Challenges, solutions, and future prospects
Kashyap Kumar Dubey, Akshay Kumar, Anshu Baldia, et al.
Biotechnology Advances (2023) Vol. 69, pp. 108267-108267
Open Access | Times Cited: 10

The Question of HIV Vaccine: Why Is a Solution Not Yet Available?
Martina Libera, Valeria Caputo, Giulia Laterza, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-20
Open Access | Times Cited: 3

Tuning extracellular fluid viscosity to enhance transfection efficiency
Jingyao Ma, Yining Zhu, Jiayuan Kong, et al.
Nature Chemical Engineering (2024)
Closed Access | Times Cited: 2

Molecular mechanisms of avian immunoglobulin gene diversification and prospect for industrial applications
Hidetaka Seo, Kouji Hirota, Kunihiro Ohta
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

Prophylactic and therapeutic vaccine development: advancements and challenges
Induni Nayodhara Weerarathna, Elijah Skarlus Doelakeh, Lydia Kiwanuka, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 2

Phylogenetic analysis and antigenic epitope prediction for E6 and E7 of Alpha-papillomavirus 9 in Taizhou, China
Haobo Yuan, Ziyi Yan, Jun Gan, et al.
BMC Genomics (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 1

Exploring How Antibody Format Drives Clearance from the Brain
Kelly Schwinghamer, Brian M. Kopec, Ebehiremen Ayewoh, et al.
Molecular Pharmaceutics (2024) Vol. 21, Iss. 9, pp. 4416-4429
Closed Access | Times Cited: 1

Active Immunotherapy for the Prevention of Alzheimer’s and Parkinson’s Disease
Madeline M. Vroom, Jean‐Cosme Dodart
Vaccines (2024) Vol. 12, Iss. 9, pp. 973-973
Open Access | Times Cited: 1

Monoclonal antibodies: From magic bullet to precision weapon
Hassan Aboul-Ella, Asmaa Gohar, Aya Ahmed Ali, et al.
Molecular Biomedicine (2024) Vol. 5, Iss. 1
Open Access | Times Cited: 1

Mobilization of the innate immune response by a specific immunostimulant β-glucan confers resistance to chronic stress-induced depression-like behavior by preventing neuroinflammatory responses
Jie Ren, Yi Zhang, Hainan Pan, et al.
International Immunopharmacology (2023) Vol. 127, pp. 111405-111405
Closed Access | Times Cited: 2

The importance of immunization as a public health instrument
Marco Aurélio Palazzi Sáfadi
Jornal de Pediatria (2022) Vol. 99, pp. S1-S3
Open Access | Times Cited: 4

Advances in Nanocarriers for Delivering Therapeutic Agents Against Hepatitis B Virus
Jia Li, Jianlan Yuan, Hugang Li, et al.
Advanced NanoBiomed Research (2024) Vol. 4, Iss. 6
Open Access

Personalized vaccines, novel vaccination technologies, and future prospects
Srivatsa Surya Vasudevan, Tiba Yamin Kandrikar, Adil Ali Sayyed, et al.
Elsevier eBooks (2024), pp. 225-242
Closed Access

Page 1 - Next Page

Scroll to top